Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Am J Obstet Gynecol. 2017 Feb 7;216(5):529.e1–529.e8. doi: 10.1016/j.ajog.2017.01.040

Figure 3.

Figure 3

Fetal heart rate variability. Buprenorphine administration was associated with significantly reduced fetal heart rate variability at 32 and 36 weeks gestation no difference was observed at earlier gestational ages.